ES2092500T3 - Derivados de cyclosporin. - Google Patents

Derivados de cyclosporin.

Info

Publication number
ES2092500T3
ES2092500T3 ES90810567T ES90810567T ES2092500T3 ES 2092500 T3 ES2092500 T3 ES 2092500T3 ES 90810567 T ES90810567 T ES 90810567T ES 90810567 T ES90810567 T ES 90810567T ES 2092500 T3 ES2092500 T3 ES 2092500T3
Authority
ES
Spain
Prior art keywords
cyclosporin derivatives
ser
ciclosporin
derivatives
immunosuppressants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90810567T
Other languages
English (en)
Inventor
Marcel Karl Eberle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of ES2092500T3 publication Critical patent/ES2092500T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

UNOS DERIVADOS [(D)SER]-CICLOSPORINA HIDROXI SUSTITUIDOS, PARTICULARMENTE [O-(2-HIDROXIETIL)(D)SER]8-CICLOSPORINA, TIENEN PROPIEDADES FARMACEUTICAS VENTAJOSAS Y SON UTILES COMO INMUNOPRESORES POR EJEMPLO, EN EL TRATAMIENTO DE ENFERMEDADES AUTOINMUNES O POR TRANSPLANTE.
ES90810567T 1989-07-24 1990-07-23 Derivados de cyclosporin. Expired - Lifetime ES2092500T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898916901A GB8916901D0 (en) 1989-07-24 1989-07-24 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
ES2092500T3 true ES2092500T3 (es) 1996-12-01

Family

ID=10660543

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90810567T Expired - Lifetime ES2092500T3 (es) 1989-07-24 1990-07-23 Derivados de cyclosporin.

Country Status (23)

Country Link
EP (1) EP0414632B1 (es)
JP (1) JPH0730113B2 (es)
KR (1) KR100201174B1 (es)
AT (1) ATE144536T1 (es)
AU (1) AU631667B2 (es)
CA (1) CA2021788C (es)
CZ (1) CZ411691A3 (es)
DE (1) DE69028967T2 (es)
DK (1) DK0414632T3 (es)
ES (1) ES2092500T3 (es)
FI (1) FI94355C (es)
GB (1) GB8916901D0 (es)
GR (1) GR3021667T3 (es)
HK (1) HK1004268A1 (es)
HU (1) HU206127B (es)
IE (1) IE902669A1 (es)
IL (1) IL95154A (es)
MY (1) MY105942A (es)
NZ (1) NZ234613A (es)
PT (1) PT94790B (es)
SA (1) SA91110205B1 (es)
SK (1) SK411691A3 (es)
ZA (1) ZA905823B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
GB9204466D0 (en) * 1992-03-02 1992-04-15 Sandoz Ltd Improvements in or relating to organic compounds
US5482850A (en) * 1993-10-29 1996-01-09 New England Biolabs, Inc. Method for identifying anti-parasitic compounds
EP0852233A4 (en) * 1995-09-21 1999-09-15 Nippon Shinyaku Co Ltd CYCLOSPORIN PHOSPHATE DERIVATIVES AND MEDICINAL COMPOSITION
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US6790228B2 (en) 1999-12-23 2004-09-14 Advanced Cardiovascular Systems, Inc. Coating for implantable devices and a method of forming the same
US7807211B2 (en) 1999-09-03 2010-10-05 Advanced Cardiovascular Systems, Inc. Thermal treatment of an implantable medical device
KR100681670B1 (ko) * 2001-02-14 2007-02-09 주식회사 엘지생활건강 [감마 히드록시 엔- 메틸-엘-루신9]사이클로스포린 에이를유효성분으로 하는 모발 성장 촉진제
KR100465012B1 (ko) 2001-05-11 2005-01-13 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
WO2003033526A2 (en) 2001-10-19 2003-04-24 Isotechnika Inc. Synthesis of cyclosporin analogs
KR100865211B1 (ko) * 2001-10-26 2008-10-23 주식회사 엘지생활건강 비면역 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린 유도체를 유효성분으로 하는 항암 화학요법 기인 탈모증상 억제제
US6987090B2 (en) 2002-05-09 2006-01-17 Lg Household & Health Care Ltd. Use of 3-position cyclosporin derivatives for hair growth
KR100439467B1 (ko) * 2002-11-13 2004-07-09 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
FR2873585B1 (fr) * 2004-07-27 2006-11-17 Aventis Pharma Sa Nouvelles formulations galeniques de principes actifs
WO2008069917A2 (en) 2006-11-20 2008-06-12 Scynexis, Inc. Novel cyclic peptides
US8796221B2 (en) * 2011-11-15 2014-08-05 Allergan, Inc. Cyclosporin A form 2 and method of making same
WO2020037530A1 (en) * 2018-08-22 2020-02-27 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Crystalline form of compound and uses thereof in medicine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (es) 1975-11-04 1979-12-28 Sandoz Ag
DE2819094A1 (de) 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
SE448386B (sv) 1978-10-18 1987-02-16 Sandoz Ag Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem
EP0098457B1 (en) 1980-02-14 1987-08-05 Sandoz Ag (1s,2r,3r)- and (1r,2s,3s)-nitrilo-1-carbonyl-3-methyl-2-oxy-heptanes and -hept-5-enes useful in the total synthesis of cyclosporins and processes for their production
US4396542A (en) 1980-02-14 1983-08-02 Sandoz Ltd. Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
EP0056782B1 (en) 1981-01-09 1984-08-01 Sandoz Ag Novel cyclosporins
CH667274A5 (de) 1984-03-23 1988-09-30 Sandoz Ag Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE92501T1 (de) 1984-10-04 1993-08-15 Sandoz Ag Monoklonale antikoerper gegen zyklosporine.
US4798823A (en) 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
ATE95193T1 (de) * 1987-06-17 1993-10-15 Sandoz Ag Cyclosporine und deren benutzung als arzneimittel.
GB2206119B (en) 1987-06-22 1990-10-31 Merck & Co Inc A new cyclosporin derivative with modified "8-amino acid"
GB8717300D0 (en) 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
GB8717299D0 (en) 1987-07-22 1987-08-26 Nat Res Dev Peptides
GB2207678A (en) 1987-08-03 1989-02-08 Merck & Co Inc Novel immunosuppressive fluorinated cyclosporin analogs
HU205010B (en) 1987-09-15 1992-03-30 Sandoz Ag Process for producing pharmaceutical compositions comprising compounds soluble up to 1 per cent and having medical activity
GB2222770B (en) 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins

Also Published As

Publication number Publication date
IE902669A1 (en) 1991-02-27
EP0414632B1 (en) 1996-10-23
EP0414632A3 (en) 1991-09-11
IL95154A (en) 1995-03-30
FI94355B (fi) 1995-05-15
HUT54714A (en) 1991-03-28
DE69028967T2 (de) 1997-05-15
SA91110205B1 (ar) 2004-08-07
CZ411691A3 (cs) 1998-06-17
GB8916901D0 (en) 1989-09-06
FI94355C (fi) 1995-08-25
DK0414632T3 (da) 1996-11-25
SK411691A3 (en) 1995-07-11
DE69028967D1 (de) 1996-11-28
KR910002902A (ko) 1991-02-26
NZ234613A (en) 1992-09-25
KR100201174B1 (ko) 1999-06-15
HU904224D0 (en) 1990-12-28
MY105942A (en) 1995-02-28
JPH0730113B2 (ja) 1995-04-05
ZA905823B (en) 1992-03-25
CA2021788C (en) 2001-02-13
GR3021667T3 (en) 1997-02-28
AU631667B2 (en) 1992-12-03
AU5972790A (en) 1991-01-24
CA2021788A1 (en) 1991-01-25
FI903706A0 (fi) 1990-07-23
PT94790A (pt) 1991-03-20
HU206127B (en) 1992-08-28
JPH03218396A (ja) 1991-09-25
IL95154A0 (en) 1991-06-10
EP0414632A2 (en) 1991-02-27
ATE144536T1 (de) 1996-11-15
PT94790B (pt) 1997-04-30
HK1004268A1 (en) 1998-11-20

Similar Documents

Publication Publication Date Title
ES2092500T3 (es) Derivados de cyclosporin.
MX9101869A (es) Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas
ZA917744B (en) Fused ring analogs of nitrogen containing nonaromatic heterocycles.
KR950702564A (ko) 비스-스타우로스포린 및 케이-252에이(K-25a)유도체(BIS-STAUROSPORINE AND K-252a DERIVATIVES)
ES2125233T3 (es) Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina.
FR2670669B1 (fr) Instrument de correction chirurgicale de l'astigmatisme.
DE3886986D1 (de) Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens.
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
HU9201468D0 (en) Reduced rapamycin derivatives and medical preparations containing them
FR2694021B1 (fr) Procédé de préparation d'un pigment indolique ou indolinique par voie enzymatique, pigment obtenu et son utilisation en cosmétique.
DE69028147T2 (de) Antikonvulsive Pirazine
WO1990010006A3 (de) NEUE β-METHOXYACRYLATE, IHRE HERSTELLUNG UND VERWENDUNG
DE68928885T2 (de) 1-Dimethylcarbamoyl-1H-1,2,4-triazole-substituiert in Stellungen 3 und 5
EP0317749A3 (en) Substituted benzimidazoles and benzothiadiazoles
DE59007185D1 (de) Substituierte 1.2.3.4-Oxatriazolium-5-olate, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE3886101D1 (de) 14-Chlorodaunomycin und Verfahren zur Herstellung von 14-Chlorodaunomycin und Verfahren zur Herstellung von (2"R)-4'-O-Tetrahydropyramyladriamycin.
DE9007721U1 (de) Metallimplantat für medizinische Zwecke
GB8713666D0 (en) Company secretary's organiser
HUT57447A (en) Single stage aspherical lens of high numerical aperture
DE3787471T2 (de) 4"-Desoxy-3"-demethoxy-3"-methylen-desmycosin-Derivate.
GB8712479D0 (en) Treating transplant rejection
KR900017531U (ko) 현미경 대물렌즈(對物 lens)
FR2643645B1 (fr) Laque solaire, composition et procede d'obtention
HUT57777A (en) Process for producing pyrido(2,3-8)(1,5)benzoxazepin- (and thiazepin)-5(6)-ones and -thiones, as well as pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 414632

Country of ref document: ES